Adiponectin, HOMA-Adiponectin, HOMA-IR in children and adolescents : Ouro Preto study.

dc.contributor.authorCândido, Ana Paula Carlos
dc.contributor.authorGeloneze, Bruno
dc.contributor.authorCalixto, Aurea Oliveira Silva
dc.contributor.authorVasques, Ana Carolina Junqueira
dc.contributor.authorFreitas, Renata Nascimento de
dc.contributor.authorFreitas, Silvia Nascimento de
dc.contributor.authorCoelho, George Luiz Lins Machado
dc.date.accessioned2021-12-09T15:20:52Z
dc.date.available2021-12-09T15:20:52Z
dc.date.issued2020pt_BR
dc.description.abstractObjectives To examine the association and predictive capacity of adiponectin levels, HOMA-AD and HOMA-IR indexes with metabolic risk markers in children and adolescents. Methods A cross-sectional study was conducted with 691 children and adolescents (7–14 y), of both sexes. Demographic (sex, age), anthropometric (weight, height, body mass index, waist circumference, body fat), biochemical [total cholesterol, high density lipoprotein (HDL), low density lipoprotein (LDL), triglycerides, fasting glycemia, insulin and adiponectin] and clinical parameters (arterial blood pressure) were analyzed. Results In multiple linear regression models, metabolic risk were analyzed in relation to adiponectin levels, HOMA-AD and HOMA-IR. ROC curve analysis was used to define the cut-off for metabolic syndrome for each method studied. Adiponectin level was inversely correlated with weight (r = −0.12; p = 0.01), waist circumference (WC) (r = −0.12; p = 0.01), and triglycerides (r = −0.11; p = 0.02); it was directly correlated with HDL (r = 0.10; p = 0.03) only in the adolescents. In the final linear regression model, after adjustment, only triglycerides (p = 0.03) and HDL (p = 0.04) remained significant. However, HOMA-AD and HOMA-IR were associated with metabolic risk and were the most suitable methods for metabolic syndrome screening in both age groups. For children, independent variables explained 16.0% and 14.5% of HOMA-AD and HOMA-IR, respectively. For adolescents, R2 was higher in HOMA-AD and HOMA-IR models (R2 adjusted = 31.9% and R2 adjusted = 29.6%, respectively). Conclusions HOMA-AD and HOMA-IR are better explained by metabolic markers than adiponectin levels.pt_BR
dc.identifier.citationCÂNDIDO, A. P. C. et al. Adiponectin, HOMA-Adiponectin, HOMA-IR in children and adolescents: Ouro Preto study. The Indian Journal of Pediatrics, v. 88, p. 336–344, 2020. Disponível em: <https://link.springer.com/article/10.1007%2Fs12098-020-03444-3>. Acesso em: 10 jun. 2021.pt_BR
dc.identifier.doihttps://doi.org/10.1007/s12098-020-03444-3pt_BR
dc.identifier.issn0019-5456
dc.identifier.urihttp://www.repositorio.ufop.br/jspui/handle/123456789/14137
dc.identifier.uri2https://link.springer.com/article/10.1007%2Fs12098-020-03444-3pt_BR
dc.language.isoen_USpt_BR
dc.rightsrestritopt_BR
dc.titleAdiponectin, HOMA-Adiponectin, HOMA-IR in children and adolescents : Ouro Preto study.pt_BR
dc.typeArtigo publicado em periodicopt_BR
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
ARTIGO_AdiponectinHomaAdiponectin.pdf
Size:
618.31 KB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: